{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:59:22Z","timestamp":1793393962570,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"associazione italiana per la ricerca sul cancro","doi-asserted-by":"publisher","award":["ID. 21406"],"award-info":[{"award-number":["ID. 21406"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Thymic epithelial tumors (TETs) are rare neoplasms, originating from epithelial thymic cells. The oncogenic potential of these rare neoplasms is still largely undefined, and a deeper molecular characterization could result in a relevant advance in their management, greatly improving diagnosis, prognosis and treatment choice. Deregulation of N6-methyladenosine (m<jats:sup>6<\/jats:sup>A) RNA modification, catalyzed by the METTL3\/METTL14 methyltransferase complex, is emerging as a relevant event in cell differentiation and carcinogenesis. Various studies have reported that altered expression of METTL3 is associated with an aggressive malignant phenotype and favors migration and invasiveness, but its role in Thymic Tumors remains unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In this study, we characterized that METTL3 contributes to Thymic Epithelial Tumor phenotype. We evidenced that METTL3 is overexpressed in tumor tissue compared to normal counterpart. Silencing of METTL3 expression in thymic carcinoma cells results in reduced cell proliferation and overall translation rate. Of note, METTL3 is responsible for the induction of c-MYC expression in TET cells. Specifically, high expression of c-MYC protein is enabled by lncRNA MALAT1, which is methylated and delocalized by METTL3. Interestingly, blocking of c-MYC by using JQ1 inhibitor cooperates with METTL3 depletion in the inhibition of proliferation and induction of cell death.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study highlighted METTL3 as a tumor promoter in Thymic tumors and c-MYC as a promising target to be exploited for the treatment of TET.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13148-021-01159-6","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T12:02:53Z","timestamp":1631793773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["METTL3-dependent MALAT1 delocalization drives c-Myc induction in thymic epithelial tumors"],"prefix":"10.1186","volume":"13","author":[{"given":"Alessia","family":"Iaiza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Tito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaira","family":"Ianniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ganci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Laquintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Sacconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Masciarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Aversa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Diso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Anile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Petrozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Facciolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Melis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Pescarmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Venuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Blandino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Fontemaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Fatica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2910-7912","authenticated-orcid":false,"given":"Francesco","family":"Fazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"issue":"26","key":"1159_CR1","doi-asserted-by":"publisher","first-page":"v40","DOI":"10.1093\/annonc\/mdv277","volume":"1","author":"N Girard","year":"2015","unstructured":"Girard N, Ruffini E, Marx A, Faivre-Finn C, Peters S. Thymic epithelial tumours: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;1(26):v40-55.","journal-title":"Ann Oncol"},{"issue":"9","key":"1159_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. WHO classification of tumours of the lung, pleura, thymus and heart. J Thorac Oncol. 2015;10(9):1243\u201360.","journal-title":"J Thorac Oncol"},{"key":"1159_CR3","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1097\/JTO.0000000000000654","volume":"10","author":"A Marx","year":"2015","unstructured":"Marx A, Chan JKC, Coindre JM, Detterbeck F, Girard N, Harris NL, et al. The 2015 world health organization classification of tumors of the thymus continuity and changes. J Thoracic Oncol. 2015;10:1383\u201395.","journal-title":"J Thoracic Oncol"},{"issue":"9","key":"1159_CR4","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1097\/JTO.0000000000000290","volume":"9","author":"FC Detterbeck","year":"2014","unstructured":"Detterbeck FC, Stratton K, Giroux D, Asamura H, Crowley J, Falkson C, et al. The IASLC\/ITMIG thymic epithelial tumors staging project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol. 2014;9(9):S65-72.","journal-title":"J Thorac Oncol"},{"issue":"11","key":"1159_CR5","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","volume":"48","author":"A Masaoka","year":"1981","unstructured":"Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48(11):2485\u201392.","journal-title":"Cancer"},{"key":"1159_CR6","doi-asserted-by":"publisher","first-page":"546149","DOI":"10.1155\/2014\/546149","volume":"2014","author":"S Sioletic","year":"2014","unstructured":"Sioletic S, Lauriola L, Gallo E, Martucci R, Evoli A, Palmieri G, et al. Diagnostic features and subtyping of thymoma lymph node metastases. Biomed Res Int. 2014;2014:546149.","journal-title":"Biomed Res Int"},{"issue":"9","key":"1159_CR7","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1200\/JCO.1997.15.9.3093","volume":"15","author":"PJ Loehrer","year":"1997","unstructured":"Loehrer PJ, Chen M, Kim K, Aisner SC, Einhorn LH, Livingston R, et al. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol. 1997;15(9):3093\u20139.","journal-title":"J Clin Oncol"},{"key":"1159_CR8","doi-asserted-by":"publisher","first-page":"S3121","DOI":"10.21037\/jtd.2018.07.134","volume":"10","author":"M Anile","year":"2018","unstructured":"Anile M, Poggi C, Diso D, Pecoraro Y, Rendina EA, Venuta F. Wind of change in surgical treatment of thymic tumors. J Thoracic Disease. 2018;10:S3121\u20133.","journal-title":"J Thoracic Disease"},{"issue":"10","key":"1159_CR9","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3389\/fonc.2020.00922","volume":"14","author":"E Melis","year":"2020","unstructured":"Melis E, Gallo E, di Martino S, Gallina FT, Laquintana V, Casini B, et al. Thymic epithelial tumors as a model of networking: development of a synergistic strategy for clinical and translational research purposes. Front Oncol. 2020;14(10):922.","journal-title":"Front Oncol"},{"issue":"2","key":"1159_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ccell.2018.01.003","volume":"33","author":"M Radovich","year":"2018","unstructured":"Radovich M, Pickering CR, Felau I, Ha G, Zhang H, Jo H, et al. The integrated genomic landscape of thymic epithelial tumors. Cancer Cell. 2018;33(2):244-258.e10.","journal-title":"Cancer Cell"},{"issue":"11","key":"1159_CR11","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/s41419-020-03171-9","volume":"11","author":"C Tito","year":"2020","unstructured":"Tito C, Ganci F, Sacconi A, Masciarelli S, Fontemaggi G, Pulito C, et al. LINC00174 is a novel prognostic factor in thymic epithelial tumors involved in cell migration and lipid metabolism. Cell Death Dis. 2020;11(11):959.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1159_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-017-0655-2","volume":"16","author":"T Bellissimo","year":"2017","unstructured":"Bellissimo T, Ganci F, Gallo E, Sacconi A, Tito C, De Angelis L, et al. Thymic epithelial tumors phenotype relies on miR-145-5p epigenetic regulation. Mol Cancer. 2017;16(1):88.","journal-title":"Mol Cancer"},{"issue":"2","key":"1159_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.lungcan.2014.04.008","volume":"85","author":"F Ganci","year":"2014","unstructured":"Ganci F, Vico C, Korita E, Sacconi A, Gallo E, Mori F, et al. MicroRNA expression profiling of thymic epithelial tumors. Lung Cancer. 2014;85(2):197\u2013204.","journal-title":"Lung Cancer"},{"issue":"4","key":"1159_CR14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.molcel.2016.01.012","volume":"61","author":"W Xiao","year":"2016","unstructured":"Xiao W, Adhikari S, Dahal U, Chen Y-S, Hao Y-J, Sun B-F, et al. Nuclear m 6 A reader YTHDC1 regulates mRNA splicing-supplemental information. Mol Cell. 2016;61(4):507\u201319.","journal-title":"Mol Cell"},{"issue":"7574","key":"1159_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nature15377","volume":"526","author":"J Zhou","year":"2015","unstructured":"Zhou J, Wan J, Gao X, Zhang X, Jaffrey SR, Qian SB. Dynamic m6 A mRNA methylation directs translational control of heat shock response. Nature. 2015;526(7574):591\u20134.","journal-title":"Nature"},{"issue":"3","key":"1159_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","volume":"62","author":"S Lin","year":"2016","unstructured":"Lin S, Choe J, Du P, Triboulet R, Gregory RI. The m6A methyltransferase METTL3 promotes translation in human cancer cells. Mol Cell. 2016;62(3):335\u201345.","journal-title":"Mol Cell"},{"issue":"7481","key":"1159_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, et al. N 6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505(7481):117\u201320.","journal-title":"Nature"},{"key":"1159_CR18","doi-asserted-by":"publisher","first-page":"e31311","DOI":"10.7554\/eLife.31311","volume":"6","author":"IA Roundtree","year":"2017","unstructured":"Roundtree IA, Luo GZ, Zhang Z, Wang X, Zhou T, Cui Y, et al. YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs. Elife. 2017;6:e31311.","journal-title":"Elife"},{"key":"1159_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrm.2016.132","volume":"18","author":"BS Zhao","year":"2016","unstructured":"Zhao BS, Roundtree IA, He C. Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol. 2016;18:31\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"22","key":"1159_CR20","first-page":"3936","volume":"27","author":"F Zhang","year":"2018","unstructured":"Zhang F, Kang Y, Wang M, Li Y, Xu T, Yang W, et al. Fragile X mental retardation protein modulates the stability of its m6A-marked messenger RNA targets. Hum Mol Genet. 2018;27(22):3936\u201350.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"1159_CR21","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.stem.2014.09.019","volume":"15","author":"PJ Batista","year":"2014","unstructured":"Batista PJ, Molinie B, Wang J, Qu K, Zhang J, Li L, et al. M6A RNA modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell. 2014;15(6):707\u201319.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"1159_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","volume":"22","author":"H Weng","year":"2018","unstructured":"Weng H, Huang H, Wu H, Qin X, Zhao BS, Dong L, et al. METTL14 inhibits hematopoietic stem\/progenitor differentiation and promotes leukemogenesis via mRNA m6A modification. Cell Stem Cell. 2018;22(2):191-205.e9.","journal-title":"Cell Stem Cell"},{"key":"1159_CR23","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20:608\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"1159_CR24","first-page":"1233","volume":"3","author":"JA Bokar","year":"1997","unstructured":"Bokar JA, Shambaugh ME, Polayes D, Matera AG, Rottman FM. Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase. RNA. 1997;3(11):1233\u201347.","journal-title":"RNA"},{"issue":"September","key":"1159_CR25","doi-asserted-by":"publisher","first-page":"e18434","DOI":"10.7554\/eLife.18434","volume":"5","author":"P \u015aled\u017a","year":"2016","unstructured":"\u015aled\u017a P, Jinek M. Structural insights into the molecular mechanism of the m6A writer complex. Elife. 2016;5(September):e18434.","journal-title":"Elife"},{"issue":"2","key":"1159_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/cr.2014.3","volume":"24","author":"XL Ping","year":"2014","unstructured":"Ping XL, Sun BF, Wang L, Xiao W, Yang X, Wang WJ, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 2014;24(2):177\u201389.","journal-title":"Cell Res"},{"key":"1159_CR27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.bbagrm.2018.09.008","volume":"1862","author":"S Lesbirel","year":"2019","unstructured":"Lesbirel S, Wilson SA. The m 6 A-methylase complex and mRNA export. Biochimica Biophysica Acta Gene Regul Mech. 2019;1862:319\u201328.","journal-title":"Biochimica Biophysica Acta Gene Regul Mech"},{"issue":"12","key":"1159_CR28","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nchembio.687","volume":"7","author":"G Jia","year":"2011","unstructured":"Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, et al. N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7(12):885\u20137.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"1159_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","volume":"49","author":"G Zheng","year":"2013","unstructured":"Zheng G, Dahl JA, Niu Y, Fedorcsak P, Huang CM, Li CJ, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell. 2013;49(1):18\u201329.","journal-title":"Mol Cell"},{"key":"1159_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.tcb.2017.10.001","volume":"28","author":"DP Patil","year":"2018","unstructured":"Patil DP, Pickering BF, Jaffrey SR. Reading m6A in the transcriptome: m6A-binding proteins. Trends Cell Biol. 2018;28:113\u201327.","journal-title":"Trends Cell Biol"},{"issue":"10","key":"1159_CR31","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/nsmb.3462","volume":"24","author":"RR Edupuganti","year":"2017","unstructured":"Edupuganti RR, Geiger S, Lindeboom RGH, Shi H, Hsu PJ, Lu Z, et al. N6-methyladenosine (m6A) recruits and repels proteins to regulate mRNA homeostasis. Nat Struct Mol Biol. 2017;24(10):870\u20138.","journal-title":"Nat Struct Mol Biol"},{"issue":"7540","key":"1159_CR32","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nature14234","volume":"518","author":"N Liu","year":"2015","unstructured":"Liu N, Dai Q, Zheng G, He C, Parisien M, Pan T. N6 -methyladenosine-dependent RNA structural switches regulate RNA-protein interactions. Nature. 2015;518(7540):560\u20134.","journal-title":"Nature"},{"issue":"11","key":"1159_CR33","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nm.4416","volume":"23","author":"LP Vu","year":"2017","unstructured":"Vu LP, Pickering BF, Cheng Y, Zaccara S, Nguyen D, Minuesa G, et al. The N 6-methyladenosine (m 6 A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med. 2017;23(11):1369\u201376.","journal-title":"Nat Med"},{"issue":"415","key":"1159_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2017.11.018","volume":"28","author":"X Cai","year":"2018","unstructured":"Cai X, Wang X, Cao C, Gao Y, Zhang S, Yang Z, et al. HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g. Cancer Lett. 2018;28(415):11\u20139.","journal-title":"Cancer Lett"},{"issue":"4","key":"1159_CR35","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/onc.2017.351","volume":"37","author":"A Visvanathan","year":"2018","unstructured":"Visvanathan A, Patil V, Arora A, Hegde AS, Arivazhagan A, Santosh V, et al. Essential role of METTL3-mediated m 6 A modification in glioma stem-like cells maintenance and radioresistance. Oncogene. 2018;37(4):522\u201333.","journal-title":"Oncogene"},{"issue":"14","key":"1159_CR36","doi-asserted-by":"publisher","first-page":"E2047","DOI":"10.1073\/pnas.1602883113","volume":"113","author":"C Zhang","year":"2016","unstructured":"Zhang C, Samanta D, Lu H, Bullen JW, Zhang H, Chen I, et al. Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA. Proc Natl Acad Sci U S A. 2016;113(14):E2047\u201356.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1159_CR37","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/hep.29683","volume":"67","author":"M Chen","year":"2018","unstructured":"Chen M, Wei L, Law CT, Tsang FHC, Shen J, Cheng CLH, et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 2018;67(6):2254\u201370.","journal-title":"Hepatology"},{"key":"1159_CR38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3389\/fcell.2019.00116","volume":"7","author":"F Fazi","year":"2019","unstructured":"Fazi F, Fatica A. Interplay between N6-methyladenosine (M6A) and noncoding RNAs in cell development and cancer. Front Cell Dev Biol. 2019;7:116.","journal-title":"Front Cell Dev Biol"},{"issue":"7397","key":"1159_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11112","volume":"485","author":"D Dominissini","year":"2012","unstructured":"Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485(7397):201\u20136.","journal-title":"Nature"},{"issue":"5","key":"1159_CR40","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jmb.2015.08.021","volume":"428","author":"KI Zhou","year":"2016","unstructured":"Zhou KI, Parisien M, Dai Q, Liu N, Diatchenko L, Sachleben JR, et al. N6-methyladenosine modification in a long noncoding RNA hairpin predisposes its conformation to protein binding. J Mol Biol. 2016;428(5):822\u201333.","journal-title":"J Mol Biol"},{"issue":"2","key":"1159_CR41","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ygyno.2018.09.015","volume":"151","author":"W Hua","year":"2018","unstructured":"Hua W, Zhao Y, Jin X, Yu D, He J, Xie D, et al. METTL3 promotes ovarian carcinoma growth and invasion through the regulation of AXL translation and epithelial to mesenchymal transition. Gynecol Oncol. 2018;151(2):356\u201365.","journal-title":"Gynecol Oncol"},{"key":"1159_CR42","doi-asserted-by":"crossref","unstructured":"Yue B, Song C, Yang L, Cui R, Cheng X, Zhang Z, et al. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer. Mol Cancer. 2019;18(1).","DOI":"10.1186\/s12943-019-1065-4"},{"issue":"24","key":"1159_CR43","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.1038\/s41388-019-0755-0","volume":"38","author":"F Yang","year":"2019","unstructured":"Yang F, Jin H, Que B, Chao Y, Zhang H, Ying X, et al. Dynamic m6A mRNA methylation reveals the role of METTL3-m6A-CDCP1 signaling axis in chemical carcinogenesis. Oncogene. 2019;38(24):4755\u201372.","journal-title":"Oncogene"},{"issue":"7683","key":"1159_CR44","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nature24678","volume":"552","author":"I Barbieri","year":"2017","unstructured":"Barbieri I, Tzelepis K, Pandolfini L, Shi J, Mill\u00e1n-Zambrano G, Robson SC, et al. Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control. Nature. 2017;552(7683):126\u201331.","journal-title":"Nature"},{"issue":"19","key":"1159_CR45","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1038\/s41388-019-0683-z","volume":"38","author":"M Cheng","year":"2019","unstructured":"Cheng M, Sheng L, Gao Q, Xiong Q, Zhang H, Wu M, et al. The m 6 A methyltransferase METTL3 promotes bladder cancer progression via AFF4\/NF-\u03baB\/MYC signaling network. Oncogene. 2019;38(19):3667\u201380.","journal-title":"Oncogene"},{"issue":"20","key":"1159_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2020.01.033","volume":"5","author":"W Zhao","year":"2020","unstructured":"Zhao W, Cui Y, Liu L, Ma X, Qi X, Wang Y, et al. METTL3 facilitates oral squamous cell carcinoma tumorigenesis by enhancing c-myc stability via YTHDF1-mediated m6A modification. Mol Ther Nucleic Acids. 2020;5(20):1\u201312.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"4","key":"1159_CR47","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1261\/rna.028639.111","volume":"18","author":"R Miyagawa","year":"2012","unstructured":"Miyagawa R, Tano K, Mizuno RIE, Nakamura YO, Ijiri K, Rakwal R, et al. Identification of cis- and trans-acting factors involved in the localization of MALAT-1 noncoding RNA to nuclear speckles. RNA. 2012;18(4):738\u201351.","journal-title":"RNA"},{"issue":"8","key":"1159_CR48","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.15252\/embr.201643370","volume":"18","author":"M Pruszko","year":"2017","unstructured":"Pruszko M, Milano E, Forcato M, Donzelli S, Ganci F, Di Agostino S, et al. The mutant p53-ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1. EMBO Rep. 2017;18(8):1331\u201351.","journal-title":"EMBO Rep"},{"issue":"8","key":"1159_CR49","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1002\/jcb.25863","volume":"118","author":"HT Zhang","year":"2017","unstructured":"Zhang HT, Gui T, Sang Y, Yang J, Li YH, Liang GH, et al. The BET bromodomain inhibitor JQ1 suppresses chondrosarcoma cell growth via regulation of YAP\/p21\/c-myc signaling. J Cell Biochem. 2017;118(8):2182\u201392.","journal-title":"J Cell Biochem"},{"issue":"6","key":"1159_CR50","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","volume":"146","author":"JE Delmore","year":"2011","unstructured":"Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell. 2011;146(6):904\u201317.","journal-title":"Cell"},{"issue":"12","key":"1159_CR51","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/nsmb.2912","volume":"21","author":"T Kanno","year":"2014","unstructured":"Kanno T, Kanno Y, Leroy G, Campos E, Sun HW, Brooks SR, et al. BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones. Nat Struct Mol Biol. 2014;21(12):1047\u201357.","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"1159_CR52","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1101\/sqb.2016.81.030908","volume":"81","author":"S Shu","year":"2016","unstructured":"Shu S, Polyak K. BET bromodomain proteins as cancer therapeutic targets. Cold Spring Harb Symp Quant Biol. 2016;81(1):123\u20139.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"1159_CR53","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13045-020-00951-w","volume":"13","author":"C Zeng","year":"2020","unstructured":"Zeng C, Huang W, Li Y, Weng H. Roles of METTL3 in cancer: Mechanisms and therapeutic targeting. J Hematol Oncol. 2020;13:117.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"1159_CR54","first-page":"1631","volume":"10","author":"S Liu","year":"2020","unstructured":"Liu S, Zhuo L, Wang J, Zhang Q, Li Q, Li G, et al. METTL3 plays multiple functions in biological processes. Am J Cancer Res. 2020;10(6):1631\u201346.","journal-title":"Am J Cancer Res"},{"key":"1159_CR55","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41422-018-0034-6","volume":"28","author":"X Deng","year":"2018","unstructured":"Deng X, Su R, Weng H, Huang H, Li Z, Chen J. RNA N 6-methyladenosine modification in cancers: current status and perspectives. Cell Res. 2018;28:507\u201317.","journal-title":"Cell Res"},{"key":"1159_CR56","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41419-017-0129-x","volume":"9","author":"D Dai","year":"2018","unstructured":"Dai D, Wang H, Zhu L, Jin H, Wang X. N6-methyladenosine links RNA metabolism to cancer progression review-article. Cell Death Disease. 2018;9:124.","journal-title":"Cell Death Disease"},{"issue":"23","key":"1159_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2020.09.023","volume":"5","author":"M Ye","year":"2021","unstructured":"Ye M, Dong S, Hou H, Zhang T, Shen M. Oncogenic role of long noncoding RNAMALAT1 in thyroid cancer progression through regulation of the miR-204\/IGF2BP2\/m6A-MYC signaling. Mol Ther Nucleic Acids. 2021;5(23):1\u201312.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1159_CR58","doi-asserted-by":"crossref","unstructured":"Wang X, Liu C, Zhang S, Yan H, Zhang L, Jiang A, et al. N6-methyladenosine modification of MALAT1 promotes metastasis via reshaping nuclear speckles. Dev Cell. 2021;56(5).","DOI":"10.1016\/j.devcel.2021.01.015"},{"key":"1159_CR59","first-page":"454","volume-title":"Thymic malignancies: emerging systemic therapies. Current opinion in oncology","author":"N Girard","year":"2019","unstructured":"Girard N. Thymic malignancies: emerging systemic therapies. Current opinion in oncology, vol. 31. Lippincott: Williams and Wilkins; 2019. p. 454\u201360."},{"issue":"12","key":"1159_CR60","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1002\/ijc.23335","volume":"122","author":"V Ehemann","year":"2008","unstructured":"Ehemann V, Kern MA, Breinig M, Schnabel PA, Gunawan B, Schulten HJ, et al. Establishment, characterization and drug sensitivity testing in primary cultures of human thymoma and thymic carcinoma. Int J Cancer. 2008;122(12):2719\u201325.","journal-title":"Int J Cancer"},{"issue":"4","key":"1159_CR61","first-page":"3197","volume":"19","author":"S Liang","year":"2020","unstructured":"Liang S, Guan H, Lin X, Li N, Geng F, Li J. METTL3 serves an oncogenic role in human ovarian cancer cells partially via the AKT signaling pathway. Oncol Lett. 2020;19(4):3197\u2013204.","journal-title":"Oncol Lett"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-021-01159-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-021-01159-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-021-01159-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T13:05:57Z","timestamp":1631797557000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-021-01159-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1159"],"URL":"https:\/\/doi.org\/10.1186\/s13148-021-01159-6","relation":{},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,16]]},"assertion":[{"value":"3 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The use of patient material was approved by the Institutional Review Board of \u201cPoliclinico Umberto I\u201d Hospital (Rif 3262\/26.06.2014 Prot. N\u00b0 815\/14) and the Regina Elena National Cancer Institute (Rif 383\/28.5.2013 Prot. N\u00b05\/13 and Rif 447\/20.06.2013 Prot. N\u00b07\/13).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"173"}}